Redwood Scientific Announces Rapid Introduction Of New Products Over Next Three Quarters
LOS ANGELES, August 21, 2017 /PRNewswire/ -- Redwood Scientific Technologies, Inc (RST) the leader in over-the-counter medication delivered in an oral thin-film strip has announced the rapid introduction of new products to the marketplace over the next three quarters.
Redwood Scientific To Bring First Oral Thin Film Antibiotic To Market
LOS ANGELES, May 1, 2017 /PRNewswire/ -- Redwood Scientific Technologies, Inc (RST) announces that is has started the beginning stages of bringing antibiotics to market in the successful oral thin film method.
Redwood Scientific Launching Latest Product - Eupepsia Thin™
LOS ANGELES, April 1, 2017 /PRNewswire/ -- Redwood Scientific Technologies, Inc (RST) is launching its latest product, Eupepsia Thin.
Statements in this presentation that are not descriptions of historical facts are forward-looking statements relating to future events, and as such all forward-looking statements are made pursuant to the Securities Litigation Reform Act of 1995. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this presentation that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements.
These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, successful completion of the Company’s proposed restructuring, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission. There can be no assurance that our actual results will not differ materially from expectations and other factors more fully described in our public filings with the U.S. Securities and Exchange Commission, which can be reviewed at www.sec.gov.